HK Stock MarketDetailed Quotes

06821 ASYMCHEM

Watchlist

50.900
-1.450-2.77%

Trading Apr 25 14:11 CST

18.35BMarket Cap17.05P/E (TTM)

ASYMCHEM Stock Forum

Moomoo AI

Mar 5, 2024 07:15

Asymchem Laboratories (Tianjin)'s low P/E ratio may be due to investors' belief in the company's poor earnings performance. The outlook for shrinking earnings contributes to its low P/E, forming a barrier for the share price.

Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) Stock Catapults 26% Though Its Price And Business Still Lag The Market

Moomoo AI

Jan 18, 2024 09:24

Asymchem Laboratories (Tianjin)'s low P/E ratio is due to predicted declining earnings. Investors see limited potential for earnings improvement, hence a higher P/E ratio isn't justified, indicating a stagnant share price.

Investors Aren't Buying Asymchem Laboratories (Tianjin) Co., Ltd.'s (SZSE:002821) Earnings

Spinee

Jan 17, 2024 16:21

HSI Plunge Once Deepens to 620 Pts; Pharmas In Sell-off

$Hang Seng Index (800000.HK)$ plunge deepened unceasingly after midday. It once stumbled 620 pts or 3.9% to bottom at 15,245, hitting an over-14-month low; last at 15,320, down 545 pts or 3.4%, with a total turnover of $88.5 billion.
Pharmaceuticals were sold off. $REMEGEN (09995.HK)$ once collapsed 27.5% to $22.8; last at $24.9, down 21%.
$CLOVER BIO-B (02197.HK)$ nosedived 9.6% to $0.47, hitting record low. $VIVA BIOTECH (01873.HK)$ ...